News|Articles|December 6, 2024
The Future of Cell Therapies
Author(s)Charles River
When complexities of developing donor-derived cell therapies are considered, NGS emerges clearly as a better, cost-effective yet regulatory-compliant solution.
Newsletter
Stay at the forefront of biopharmaceutical innovation—subscribe to BioPharm International for expert insights on drug development, manufacturing, compliance, and more.
Related Content
Trending on BioPharm International
1
Meeting Global Demand and Delivering Faster, More Reliable Service
2
A Strategic Assessment Tool for Modernizing Buffer Preparation in Biologics Facilities
3
How India’s Biotech Ecosystem Is Shifting Toward Innovation and Global Partnerships
4
Managing Risk and Minimizing the Complexity of Your Global Single-Use Supply Chain
5
